ARCHIVES

Phase 0 Trials Signal FDA’s New Reliance On Biomarkers For Drug Development.

This article is from The Cancer Letter archive.

Vol. 32 No. 01 | January 13, 2006

Download PDF Visit The Full Archive

Related Articles

In Brief: Coalition Dinner Celebrates NCI’s 50th Anniversary, Honors Lasker, Three Ex-Senators

September 18, 1987

In Brief: Increasing Survival Through Adjuvant Therapy Seen As Adding To Cost Of Care

October 24, 1975

Wittes, Group Chairmen Agree On Payment Per Case, Other Methods To Increase Patient Accrual

August 21, 1987

Judah Folkman, Angiogenesis Pioneer, Dead at 74.

January 18, 2008

NIH Awards 24 More Grants For Women’s Health Initiative

October 14, 1994

Avon, four companies Fund NABCO Patient Information Services

January 28, 1994